Core Laboratories Inc
CLB
Market Cap$796.23M
Close$
$0.13
99.3% downside
Current Fair Value
99.3% downsideOvervalued by 99.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $796.23 Million |
|---|---|
| Enterprise Value | $960.38 Million |
| Dividend Yield | $0.04 (0.24%) |
| Earnings per Share | $0.5 |
| Beta | 0.87 |
| Outstanding Shares | 46,864,366 |
| Avg 30 Day Volume | 366,997 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 33.58 |
|---|---|
| PEG | -14.88 |
| Price to Sales | 1.7 |
| Price to Book Ratio | 4.24 |
| Enterprise Value to Revenue | 1.91 |
| Enterprise Value to EBIT | 20.72 |
| Enterprise Value to Net Income | 40 |
| Total Debt to Enterprise | 0.19 |
| Debt to Equity | 0.92 |
Revenue Sources
No data
ESG Score
No data
About Core Laboratories N.V.
4,700 employeesCore Laboratories N.V. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance. The Company has over 70 offices in more tha...